fashion -WSS

fashion

author：fashion 2025-09-02 22:20:53 - browse：11372

Eli Lilly headquarters — Kristoffer Tripplaar/AP

The drug giant Eli Lilly said Thursday that its diabetes drug Mounjaro helped patients with the condition lose 15.7% of their body weight in a clinical trial, a result that Wall Street analysts expect to pave the way for the therapy’s approval as a weight loss treatment.

Mounjaro is the latest drug in a class known as GLP-1s or incretins — the same class as Novo Nordisk’s Ozempic, which has become a sensation because of its ability to help patients lose weight. Mounjaro has shown the potential to lead to even greater weight loss than Ozempic, and industry experts expect that it will eventually generate many billions of dollars in annual sales. Analysts at SVB Securities projected in December that Mounjaro sales could reach $26.4 billion by 2030.

Eli Lilly on Thursday also announced quarterly earnings of $1.64 per share, adjusted for one-time items, slightly below analyst expectations, on sales of $6.96 billion. Sales were hurt because of a comparison to a year ago, when the company’s Covid-19 monoclonal antibodies were still on the market. Mounjaro sales for the first quarter were $586 million, largely for people with diabetes, compared to an analyst consensus of $433.2 million.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： CDC launches VaccineFinder tool to locate Covid

WSS

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

Can Threads overtake X, formerly known as Twitter? Experts weigh in.

Alabama IVF ruling threatens families facing fatal genetic disease

Boston man files lawsuit seeking to bankrupt white supremacist group he says assaulted him

Community Health Systems hospitals under DOJ investigation

A year after a Russian missile took her leg, a young Ukrainian gymnast's spirit endures

hotspot

fashion

hotspot

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

Peter Hotez and the public health issue of online harassment

An Ebola outbreak presents a new mystery involving children

Cancer drug shortages should be causing more outrage

Alabama frozen embryo ruling has major implications for IVF clinics

Medical leaders decry Supreme Court decision on affirmative action

With competition flaring, obesity drug hits goal in liver disease study

Apple is now the first public company to be valued at $3 trillion

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

leisure time

Zapping the brain for stroke rehab: Pivotal clinical trial begins

'Of course' Trump lost the 2020 election, DeSantis says after years of hedging

With competition flaring, obesity drug hits goal in liver disease study

Sage's campaign to raise awareness of postpartum depression hits a nerve

Germany receives 178 compensation applications from gay servicepeople over discrimination

Antivenom research: Lessons from HIV applied in search for universal antidote

explore

Wikipedia

hotspot

explore